![First Growth Funds Limited](/common/images/company/CNSX_FGFL.png)
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...
Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, May 10, 2024 NEW YORK, May 10...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.01 | 0.01 | 0.005 | 18175 | 0.01 | CS |
4 | 0 | 0 | 0.01 | 0.015 | 0.005 | 26457 | 0.00901004 | CS |
12 | 0 | 0 | 0.01 | 0.015 | 0.005 | 22252 | 0.00940125 | CS |
26 | 0.005 | 100 | 0.005 | 0.015 | 0.005 | 52784 | 0.00977523 | CS |
52 | 0.005 | 100 | 0.005 | 0.015 | 0.005 | 42813 | 0.00896914 | CS |
156 | -0.08 | -88.8888888889 | 0.09 | 0.1 | 0.005 | 44630 | 0.01490983 | CS |
260 | -0.24 | -96 | 0.25 | 0.28 | 0.005 | 40667 | 0.04004743 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.